| Literature DB >> 32384801 |
Felipe Mendes de Andrade de Carvalho1,2, Jaderson Kleveston Schneider1,2, Carla Viviane Freitas de Jesus1,2, Luciana Nalone de Andrade3, Ricardo Guimarães Amaral3, Jorge Maurício David4, Laíza Canielas Krause1,2, Patrícia Severino1,2,5, Cleide Mara Faria Soares1,2, Elina Caramão Bastos1,2, Francine Ferreira Padilha1,2, Silvana Vieira Flores Gomes1,2, Raffaele Capasso6, Antonello Santini7, Eliana Barbosa Souto8,9, Ricardo Luiz Cavalcanti de Albuquerque-Júnior1,2.
Abstract
Brazilian red propolis has been proposed as a new source of compounds with cytotoxic activity. Red propolis is a resinous material of vegetal origin, synthesized from the bees of the Appis mellifera family, with recognized biological properties. To obtain actives of low polarity and high cytotoxic profile from red propolis, in this work, we proposed a new solvent accelerated extraction method. A complete 23 factorial design was carried out to evaluate the influence of the independent variables or factors (e.g., temperature, number of cycles, and extraction time) on the dependent variable or response (i.e., yield of production). The extracts were analyzed by gas chromatography coupled with mass spectrometry for the identification of chemical compounds. Gas chromatography analysis revealed the presence of hydrocarbons, alcohols, ketones, ethers, and terpenes, such as lupeol, lupenone, and lupeol acetate, in most of the obtained extracts. To evaluate the cytotoxicity profile of the obtained bioactives, the 3-(4,5-dimethyl-2-thiazole)-2,5-diphenyl-2-H-tetrazolium bromide colorimetric assay was performed in different tumor cell lines (HCT116 and PC3). The results show that the extract obtained from 70 °C and one cycle of extraction of 10 min exhibited the highest cytotoxic activity against the tested cell lines. The highest yield, however, did not indicate the highest cytotoxic activity, but the optimal extraction conditions were indeed dependent on the temperature (i.e., 70 °C).Entities:
Keywords: antitumor activity; extraction; red propolis; supercritical liquids
Mesh:
Substances:
Year: 2020 PMID: 32384801 PMCID: PMC7277404 DOI: 10.3390/biom10050726
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Experimental variables used in the 23 full factorial design.
| Factors | Levels | ||
|---|---|---|---|
| Minimum Value (−) | Central Point (0) | Maximum Value (+) | |
| Number of cycles | 1 | 2 | 3 |
| Extraction time (min) | 10 | 15 | 20 |
| Temperature (°C) | 40 | 55 | 70 |
|
|
|
|
|
| 1 | −1 (1) | −1 (10) | −1 (40) |
| 2 | 1 (3) | −1 (10) | −1 (40) |
| 3 | −1 (1) | 1 (20) | −1 (40) |
| 4 | 1 (3) | 1 (20) | −1 (40) |
| 5 | −1 (1) | −1 (10) | 1 (70) |
| 6 | 1 (3) | −1 (10) | 1 (70) |
| 7 | −1 (1) | 1 (20) | 1 (70) |
| 8 | 1 (3) | 1 (20) | 1 (70) |
| 9 (PC) | 0 (2) | 0 (15) | 0 (55) |
| 10 (PC) | 0 (2) | 0 (15) | 0 (55) |
| 11 (PC) | 0 (2) | 0 (15) | 0 (55) |
Figure 1(a) Surface response chart of the 23 factorial design, representing the interactions of two distinct factors (time and cycle) favoring the determination of the best extraction conditions. (b) Surface response chart representing the interactions between the temperature and number of cycles. (c) Surface response chart representing the interactions between the time and temperature variables. (d) Pareto graph of 2 interactions between the variables applied to determine the yield as a response of the developed factorial planning. The vertical interrupted red line (in d) represents the significance of the compared variables; the right-hand side of the cut has significant representativity and the left-hand side does not present significance.
Figure 2Evaluation of the yield of red propolis extract samples obtained by the solvent accelerated extraction method, where the vertical interrupted red line represents the cutoff of 11%.
Compounds identified in the extract of red propolis by gas chromatography coupled with mass spectrometry (GC/MS) with the relative area (%) and linear temperature programmed retention index (LTPRI) of the compounds.
| Compounds | Samples | LTPRI | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||||
|
|
|
|
|
| ||||||||||
| Toluene | 8.0 | 2.5 | 2.6 | 2.1 | 13.2 | 3.3 | 7.8 | 17.9 | - | 5.5 | 4.0 | 774 | 774 | 0 |
| Benzene, 1,2,3-trimethyl- | 0.5 | 6.1 | 0.6 | 4.4 | - | 3.6 | 2.9 | 7.2 | - | - | 2.0 | 990 | 992 | 2 |
| Benzene, 1,2,4-trimethyl- | 3.3 | 2.0 | 5.4 | 1.1 | 8.7 | 0.9 | 0.8 | 1.7 | 5.3 | 2.7 | 0.7 | 976 | 976 | 0 |
| Indane | 0.6 | 0.3 | - | - | 0.4 | - | - | - | - | - | - | 1031 | 1032.4 | 1,4 |
| Benzene, 1,2-diethyl- | 0.3 | - | - | - | - | - | - | - | - | - | - | 1046 | 1045 | −1 |
| Benzene, 1-methyl-3-propyl- | 0.4 | 0.3 | - | - | 0.4 | - | - | - | - | - | - | 1048 | 1049 | 1 |
| Benzene, 1,4-diethyl- | 0.4 | 0.5 | - | - | 0.5 | - | - | - | - | - | - | 1052 | 1053 | 1 |
| Benzene, 1,3-diethyl- | - | - | - | - | 0.5 | - | - | - | - | - | - | 1054 | 1054 | 0 |
| Benzene, 2-ethyl-1,4-dimethyl- | 0.6 | 0.2 | - | - | 0.4 | - | - | - | - | - | - | 1082 | 1085.2 | 4,3 |
| Benzene, 4-ethyl-1,2-dimethyl- | - | - | - | - | 0.3 | - | - | - | - | - | - | 1083 | 1083 | 0 |
| Benzene, 1,2,3-trimetoxy-5-(2-propenyl)- | - | - | 0.7 | 0.5 | 0.4 | 0.4 | 0.3 | - | - | - | - | 1554 | 1554 | 0 |
|
|
| |||||||||||||
| Tricosane | - | - | 4.0 | 2.4 | 2.0 | 3.0 | 0.2 | 3.0 | 4.0 | 3.5 | 0.4 | 2299 | 2300 | 1 |
| Pentacosane | 15.1 | 10.5 | 14.5 | 8.4 | 6.1 | 7.9 | 0.6 | 10.5 | 11.1 | 10.3 | 0.8 | 2499 | 2500 | 1 |
| Hexacosane | - | 0.4 | 1.4 | 0.9 | 1.0 | 0.8 | 0.8 | 0.2 | 1.5 | 0.6 | 0.4 | 2599 | 2600 | 1 |
| Heptacosane | 0.2 | 24.6 | 25.0 | 19.1 | 19.9 | - | - | - | - | - | 1.2 | 2701 | 2700 | −1 |
| Octacosane | 0.5 | 1.0 | 0.7 | 0.8 | 0.8 | 0.7 | 0.4 | 1.3 | 0.4 | 0.3 | 0.1 | 2799 | 2800 | 1 |
| Nonacosane | 0.1 | 2.5 | 1.8 | 11.9 | 10.2 | 16.6 | 13.0 | 16.2 | 21.0 | 15.8 | 14.2 | 2899 | 2900 | 1 |
| Triacontane | - | 1.5 | 20.4 | 0.9 | - | 0.9 | 0.7 | 0.7 | 1.1 | 1.0 | 1.0 | 2998 | 3000 | 2 |
| Untriacontane | 0.2 | 23.0 | - | 17.6 | - | 18.5 | 20.0 | 22.4 | 31.0 | 21.3 | 19.9 | 3108 | 3100 | −8 |
|
|
| |||||||||||||
| Heptacos-1-ene | - | - | - | - | 0.3 | 0.9 | 2.1 | 0.3 | 0.8 | 0.5 | 20.2 | 2674 | 2684.2 | 10.2 |
| Nonacos-1-ene | - | - | 1.4 | 1.1 | - | - | - | - | - | - | - | 2875 | 2877 | 2 |
|
|
| |||||||||||||
| 1-Pentanol, 2,3-dimethyl- | - | - | - | - | 0.4 | - | - | 0.7 | - | - | - | 809 | 827 | 18 |
| 2-Hexyn-1-ol | - | - | - | - | 2.4 | - | - | - | - | - | - | 846 | 847 | 1 |
| 1-Butanol, 3-methyl-, acetate | 3.2 | 1.0 | 1.6 | 0.9 | 5.0 | 1.0 | 2.4 | 4.2 | 2.7 | 1.5 | - | 872 | 872 | 0 |
| Behenic alcohol | 2.1 | 0.6 | - | 0.3 | - | 0.4 | 7.2 | 0.4 | 0.5 | 0.3 | 8.6 | 2473 | 2470 | −3 |
| Octacosanol | - | - | - | 3.7 | - | 4.8 | 3.8 | 2.7 | 1.1 | 3.7 | 5.1 | 3098 | 3110.6 | 12.6 |
| 1-Heptacosanol | - | - | - | 16.0 | - | - | 15.6 | 2.1 | - | 15.8 | - | 3297 | 3307 | −10 |
| 1-Triacontanol | - | - | - | - | - | 17.6 | - | - | - | - | - | 3306 | 3306 | 0 |
|
|
| |||||||||||||
| Methyleugenol | - | - | 0.6 | 0.4 | 0.6 | 0.3 | 0.2 | - | - | - | - | 1401 | 1401 | 0 |
| Isopropyl tetracosyl ether | - | - | - | - | 0.7 | - | - | - | - | - | - | 2998 | 3000 | 2 |
|
|
| |||||||||||||
| Acetofenone | - | - | - | - | 0.5 | - | - | - | 3.0 | - | 0.8 | 1061 | 1061 | 0 |
| 2 (3H) -furanone, 5-dodecildi-hidro- | 1.2 | 3.6 | 5.1 | - | 2.0 | 5.4 | 2.7 | 3.6 | 5.4 | 6.2 | 4.6 | 2100 | 2104.3 | 4.3 |
|
|
| |||||||||||||
| Lupenone | - | - | - | - | - | - | - | - | 11.9 | 10.8 | 12.2 | 3384 | 3384.2 | 0,2 |
| Lupeol | - | - | - | - | 20.3 | 6.6 | 8.8 | 0.1 | - | - | - | 3499 | 3500 | 1 |
| Lupeol acetate | 16.4 | 17.5 | 10.6 | 6.1 | 3.0 | 3.4 | 3.7 | 0.2 | - | - | - | 3533 | 3525 | −8 |
Figure 3Cytotoxic analysis against tumor cell lines derived from human malignant neoplasms HCT116 (colon adenocarcinoma) and PC3 (prostate adenocarcinoma). - - - - Minimum percentage limit of cytotoxic activity considered to be at least moderate. Minimal percentage limit of cytotoxic activity considered strong.
Figure 4Average inhibitory concentration graph capable of causing 50% of the maximal effect in HCT116 cells.